http://blog.pharmexec.com/2009/03/04/pfizer-acquires-generics-branded-ophthalics/ The Business of Pharmaceuticals Wed, 10 Mar 2010 16:21:20 -0500 hourly 1 http://blog.pharmexec.com/2009/03/04/pfizer-acquires-generics-branded-ophthalics/comment-page-1/#comment-26809 Finally…Roche buys Genentech | Bioasis Technologies Inc. Mon, 30 Mar 2009 20:22:43 +0000 http://blog.pharmexec.com/?p=660#comment-26809 [...] Overall, this acquisition is quite different from the Pfizer and Merck deals. Roche has gone deeper into the biotech drugs pipeline, now gaining full control of successful drugs like Rituxan and Avastin. Pfizer and Merck in contrast made their deals to diversify across their brand drugs, biologics, animal health and generics divisions (see Pfizer’s deal with Aurobindo research here). [...] [...] Overall, this acquisition is quite different from the Pfizer and Merck deals. Roche has gone deeper into the biotech drugs pipeline, now gaining full control of successful drugs like Rituxan and Avastin. Pfizer and Merck in contrast made their deals to diversify across their brand drugs, biologics, animal health and generics divisions (see Pfizer’s deal with Aurobindo research here). [...]

]]>